Discover Great Companies Discover Great Clients
Popularity  2.1万   |   Followers  3   |   Likes  29   |   Feedback  4 Claim this company

Biopharmaceutical R&D company

No.393 Industrial Park Popularity Ranking Suzhou Jiangsu No.6 Hua He Products Design Compositing No.6 Fen Zi Sheng Wu Xue No.6 Chemistry Compositing No.7 Xi Bao Pei Yang Systems No.8 Xi Bao Pei Yang No.10 Chemistry Pharmaceuticals No.17 Innovative Drugs Products No.19 Yuan Yan Yao No.23 Pharmaceutical R&D No.25 Innovative Drugs No.49 Pharmaceutical Technology No.55 Yao Products R&D 高新技术企业 独角兽企业 省级高新技术企业 科技型中小企业 省科技型中小企业 专精特新小巨人企业
More

Company Overview

  • Nature: Listed Company Size: 100-499 employees Founded: 9年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Suzhou Sinovent Pharmaceuticals Co., Ltd.。

Development Stage

  • Stage: IPO上市, 。
  • Ranking: Ranked #6 in Suzhou Hua He Products Design Compositing Company by popularity Ranked #6 in Suzhou Fen Zi Sheng Wu Xue Company by popularity Ranked #6 in Suzhou Chemistry Compositing Company by popularity Ranked #7 in Suzhou Xi Bao Pei Yang Systems Company by popularity
  • Honors: 高新技术企业 独角兽企业 According to algorithm
  • News: 2026-10-20:信诺维:XNW26018片临床试验申请获批准。
  • Salary: 69.2% of positions earn 20-50K,。Master's salary: ¥35.2K, Doctorate salary: ¥33.1K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 53.8%, "Other (R&D and Technical)": 35.9%, "Scientific Research": 35.9%。
  • Recruiting: In 2026 vs 2025grew by 1850%. Demand for highly educated talent: Master's: 11, Doctorate: 10.
  • Requirement: Education: 硕士 leads with 33.3%. Experience: 5-10年 leads with 28.2%.
  • Region: Distributed across 2 regions, 上海: 59%, 苏州: 23.1%, 北京: 10.3%, 杭州: 2.6%.

About the Company

[Summary] Biopharmaceutical R&D company

Suzhou Sinovent Pharmaceuticals Co., Ltd. is an innovative drug company jointly founded by several overseas-returnee scientists and management and finance professionals with extensive industry resources in the pharmaceutical field. Based in China and oriented globally, the company is committed to developing into a domestic first-class and internationally renowned high-tech enterprise with independent intellectual property rights.

The company's core R&D team consists of several senior scientists with more than 20 years of R&D experience at multinational pharmaceutical companies. We also have an expert advisory team led by Dr. Ed Harlow, former vice dean of Harvard Medical School, member of four US national academies, and senior advisor to the president of the US NCI; and an industry advisory team composed of Drs. John Wang, Shuhao Zhu, Tiansheng Wang, etc., scientists with outstanding achievements in pharmaceutical R&D.

The company has built a 1,000㎡ R&D laboratory and office in Suzhou Industrial Park. Laboratories for chemical synthesis, small-scale testing, pilot testing, and chemical analysis have been completed, and laboratories for cell culture and biological testing are under preparation. It is equipped with a series of experimental equipment and instruments for molecular biology, cell biology, medicinal chemistry, chemical synthesis, and process scale-up, and can independently carry out a series of experiments in biological enzymes, proteins, cell culture, screening, testing, drug design, and synthesis scale-up. In addition, the company has an R&D office in Beijing responsible for part of product R&D, registration applications, and part of clinical support; a clinical office in Shanghai responsible for project clinical-related matters; and a R&D subsidiary in Boston, USA, responsible for new drug target discovery, early biological testing, and introduction of excellent US projects.

Currently, there are 6 main varieties under research, covering four major disease areas: oncology, antibiotics, autoimmune diseases, and metabolic diseases. The company's project development principle is first in and best in, and it has also developed a technology platform for drug target discovery with independent intellectual property rights.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Sinovent Financing History (11 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

Sinovent How Fast Is Hiring Growing? (30 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 71%
  • 2024: Down 59%
  • 2023: Down 15%
  • 2022: Down 57%
Sinovent Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Sinovent Campus Recruitment & Advanced Degree Talent Demand
Graduates 8 Master's 11 Doctorate 10
Note: How fast is hiring at Suzhou Sinovent Pharmaceuticals Co., Ltd. growing? Sinovent2026: 39 openings (up 1850%), 2025: 2 openings (down 71%), 2024: 7 openings (down 59%), 2023: 17 openings (down 15%), 2022: 20 openings (down 57%), 2021: 46 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Sinovent Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 83%
  • 2023: Up 200%
  • 2022: Up 100%
Sinovent Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Suzhou Sinovent Pharmaceuticals Co., Ltd. growing? SinoventMaster's recruitment over the years: 2025: 2 openings (flat), 2024: 2 openings (down 83%), 2023: 12 openings (up 200%), 2022: 4 openings (up 100%), 2021: 2 openings. Sinovent master talent ranking in Suzhou: #123, Sinovent master salary mostly around 20-50K.

Sinovent Doctoral Degree Job Demand Analysis

(More)
How fast is doctoral hiring at Suzhou Sinovent Pharmaceuticals Co., Ltd. growing? . Sinovent doctorate talent ranking in Suzhou: #18, Sinovent doctorate salary mostly around 20-50K and above.

Sinovent R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou Sinovent Pharmaceuticals Co., Ltd.? Based on an analysis of Sinovent's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 53.8%, "Other (R&D and Technical)": 35.9%, "Scientific Research": 35.9%, "Medical & Health/Beauty & Healthcare": 25.6%, "Computer/Network/Technology": 5.1%. For reference only.

Sinovent — What Are the Salaries Like? (39 records)

Manage
salary range: 8K - 50K, 69.2% of roles pay ¥20-50K
Note: salary statistics are based on 39 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou Sinovent Pharmaceuticals Co., Ltd.?Sinovent69.2% of positions earn 20-50K, Fresh graduate salary: ¥25.0K。Suzhou salary ranking top 5,生物/制药/化工/环保类 average salary ¥30.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Sinovent

(More)
Are salaries high at Suzhou Sinovent Pharmaceuticals Co., Ltd.? We provide: Researcher, Vice President, Academic Specialist, 科学家, Medical Manager, Drug Synthesis Specialist, Senior Director, PR, QA, RA, 临床, Analyst, Chemistry, Medical Director, 合规, Regional Manager, Process Manager, Data Specialist, Accounting Clerk, Supervisor. Click to view detailed salary analysis by job.

Sinovent honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 生物/制药/化工/环保类
    53.8% of total 53.8%
  • 其他(研发和技术类)
    35.9% of total 35.9%
  • 科研类
    35.9% of total 35.9%
  • 经营管理类
    33.3% of total 33.3%

Education

  • 硕士
    33.3% of total 33.3%
  • 博士
    33.3% of total 33.3%
  • 本科
    23.1% of total 23.1%
  • 大专
    10.3% of total 10.3%

Experience

  • 5-10年
    28.2% of total 28.2%
  • 3-5年
    23.1% of total 23.1%
  • 应届生
    20.5% of total 20.5%
  • 1-3年
    17.9% of total 17.9%
View Detailed Analysis

What does Suzhou Sinovent Pharmaceuticals Co., Ltd. require? Who is Sinovent hiring? Sinovent recruitment: 生物/制药/化工/环保类占比最多占53.8%,其次是其他(研发和技术类)占35.9%. What education can get in at Sinovent? 硕士占比最多占33.3%,其次是博士占33.3%. High education required at Sinovent? 硕士占33.3%,博士占33.3%. Work experience required at Sinovent? 5-10年占比最多占28.2%,其次是3-5年占23.1%. Where are the job locations at Sinovent? 上海占比最多占59%,其次是苏州占23.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 37,016.5663万(元)
Legal Representative: 强静
Date Established:
Credit Code: 91320594MA1P14D43F
Registered Address: 中国(江苏)自由贸易试验区苏州片区苏州工业园区桑田街218号生物医药产业园22号楼

People who follow Sinovent also follow

Sinovent Competitors (Similar Companies)

“Continuous innovation, safeguarding health”
医药 药物研发 医药工业 创新药
“To develop high-quality biologics that are accessible and affordable f”
“Green chemistry for a low-carbon beautiful life! Make the world a bett”
生命科学 生物信息 生物制药 干细胞
医疗器械 医疗耗材 再生医学 骨科植入材料
医药 生物医药 创新药 制药/药业
“Innovative supplier of overall solutions for new display technologies”
“创新药物研发商”
生物科技/生物工程 医药 蛋白质工程 生物医药
“药品生产经营服务商”
“专注于靶向肿瘤治疗小分子药物的研发”
“PCB油墨及光电化学材料”
“Leading enterprise in the power battery intelligent automation equipme”
光刻胶 聚合物 材料科技 半导体光刻

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Industrial Park”公司名录 苏州“医药”公司名录 苏州“创新药”公司名录 苏州“制药/药业”公司名录 苏州“药物研发”公司名录 苏州“分子生物学”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates